CVS Health beats on earnings, gets lift from Covid vaccines and prescription volumes

Earnings

A customer walks towards the entrance of a CVS Health Corp. store in downtown Los Angeles, California, U.S., on Friday, Oct. 27, 2017.
Christopher Lee | Bloomberg | Getty Images

CVS Health on Wednesday beat expectations for fiscal third-quarter earnings as the company got a boost from filling more prescriptions and giving more Covid-19 vaccines.

Despite that, shares of the company fell about 1% in premarket trading.

Here’s what the company reported for the three-month period ended Sept. 30, compared with what analysts were expecting, based on a survey of analysts by Refinitiv:

  • Earnings per share: $1.97 adjusted vs. $1.78 expected
  • Revenue: $73.79 billion vs. $70.49 billion expected

CVS reported third-quarter net income of $1.59 billion, or $1.20 per share, down from $1.22 billion, or 93 cents per share, a year earlier.

Excluding items, it earned $1.97 per share, more than the $1.78 per share expected by analysts surveyed by Refinitiv.

Revenue jumped to $73.79 billion from $67.06 billion a year earlier, outpacing expectations of $70.49 billion.

As of Tuesday’s close, shares of CVS were up about 33% this year. Shares touched a 52-week high on Tuesday, but closed at $91.15. The company’s market value is $120.28 billion.

Products You May Like

Articles You May Like

The CNBC FA 100 ranking recognizes advisory firms that help clients navigate their financial lives
Parents who missed out on the child tax credit of up to $3,600 have until Nov. 15 to claim it using a simple tool
Tim Cook says there are 4 traits he looks for in Apple employees: ‘It’s been a very good formula for us’
Unrelenting inflation is taking a toll, leaving more Americans living paycheck to paycheck
Some seniors make this costly Medicare enrollment mistake. A bipartisan bill looks to fix it

Leave a Reply

Your email address will not be published.